- Home
- TSI vs OPRX Comparison
TSI vs OPRX Comparison
Compare TSI & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSI
- OPRX
- Stock Information
- Founded
- TSI 1987
- OPRX 2006
- Country
- TSI United States
- OPRX United States
- Employees
- TSI N/A
- OPRX N/A
- Industry
- TSI Investment Managers
- OPRX Business Services
- Sector
- TSI Finance
- OPRX Consumer Discretionary
- Exchange
- TSI Nasdaq
- OPRX Nasdaq
- Market Cap
- TSI 236.5M
- OPRX 234.9M
- IPO Year
- TSI N/A
- OPRX N/A
- Fundamental
- Price
- TSI $4.99
- OPRX $17.33
- Analyst Decision
- TSI
- OPRX Buy
- Analyst Count
- TSI 0
- OPRX 8
- Target Price
- TSI N/A
- OPRX $11.81
- AVG Volume (30 Days)
- TSI 106.8K
- OPRX 353.6K
- Earning Date
- TSI 01-01-0001
- OPRX 11-12-2025
- Dividend Yield
- TSI 7.46%
- OPRX N/A
- EPS Growth
- TSI N/A
- OPRX N/A
- EPS
- TSI N/A
- OPRX N/A
- Revenue
- TSI N/A
- OPRX $104,748,000.00
- Revenue This Year
- TSI N/A
- OPRX $17.92
- Revenue Next Year
- TSI N/A
- OPRX $10.91
- P/E Ratio
- TSI N/A
- OPRX N/A
- Revenue Growth
- TSI N/A
- OPRX 25.89
- 52 Week Low
- TSI $4.48
- OPRX $3.78
- 52 Week High
- TSI $4.87
- OPRX $19.25
- Technical
- Relative Strength Index (RSI)
- TSI 64.26
- OPRX 52.44
- Support Level
- TSI $4.96
- OPRX $17.05
- Resistance Level
- TSI $5.00
- OPRX $18.85
- Average True Range (ATR)
- TSI 0.03
- OPRX 1.08
- MACD
- TSI 0.00
- OPRX -0.12
- Stochastic Oscillator
- TSI 86.00
- OPRX 29.41
About TSI TCW Strategic Income Fund Inc.
Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.